AndresJYarurMD

PubMed

• Pre-operative visceral adipose tissue radiodensity is a potentially novel prognostic biomarker for early endoscopic post-operative recurrence in Crohn's disease.
  Phillip Gu, Shishir Dube, Norman Gellada, So Yung Choi, Susan Win, Yoo Jin Lee, Shaohong Yang, Talin Haritunians, Gil Y Melmed, Eric A Vasiliauskas, Niru Bonthala, Gau...> ;World Journal of Gastrointestinal Surgery. 2024 Mar 27
• Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium.
  Andres J Yarur, Ryan Ungaro, Katherine Huang, Wenfei Wang, Priya Sasankan, Mir Zulqarnain, Amanda M Johnson, Geoffrey Bader, Carl Kay, Nicholas Costable, David Dulaney...> ;Inflammatory Bowel Diseases. 2024 Mar 26
• Managing Risks with Newer Oral Small Molecules in Patients with Inflammatory Bowel Diseases.
  Ayoub, M., Mattay, S., Yarur, A., Deepak, P.> ;Current Gastroenterology Reports. 2024 Feb 14
• Achievement of clinical, endoscopic, and histologic outcomes in patients with ulcerative colitis treated with etrasimod, and association with fecal calprotectin and C-...
  Panés, J., Jairath, V., Zhang, J., Rabbat, C., Sandborn, W., Vermeire, S., Peyrin-Biroulet, L., Yarur, A., Chiorean, M.> ;Journal of Crohn's & Colitis. 2024 Jan 20
• Effectiveness and safety of vedolizumab and infliximab in biologic-naive patients with Crohn's disease: results from the EVOLVE study.
  Mantzaris, G., Bressler, B., Adsul, S., Luo, M., Colby, C., Brett, N., Saha, S., Kamble, P., Wang, S., Yarur, A.> ;European Journal of Gastroenterology & Hepatology. 2024 Mar 1
• Response to Bourgonje and Mian.
  Andres J Yarur> ;The American Journal of Gastroenterology. 2023 Dec 1
• Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD).
  Phillip Gu, Shishir Dube, YooJin Lee, Shaohong Yang, Dalin Li, Talin Haritunians, Eric Vasiliauskas, Niru Bonthala, Gaurav Syal, Andres Yarur, David Ziring, Stephan Ta...> ;Digestive Diseases and Sciences. 2024 Jan 1
• The Safety, Tolerability, Pharmacokinetics and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study.
  Bram Verstockt, Severine Vermeire, Laurent Peyrin-Biroulet, Rebecca Mosig, Brian G Feagan, Jean-Frederic Colombel, Britta Siegmund, Florian Rieder, Stefan Schreiber, A...> ;Journal of Crohn's & Colitis. 2023 Nov 11
• Reply.
  Andres J Yarur, Parakkal Deepak> ;Gastroenterology. 2024 Feb 1
• ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse.
  Vipul Jairath, Andres Yarur, Mark T Osterman, Alexandra James, Diane Balma, Shailly Mehrotra, Lili Yang, Vijay Yajnik, Rana M Qasim Khan> ;Clinical Gastroenterology and Hepatology. 2023 Nov 10
• A Review of Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Receiving Combination Therapy.
  Sanket Patel, Andres J Yarur> ;Journal of Clinical Medicine. 2023 Oct 17
• 1 citations
  Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis.
  Shivani Shah Mattay, Mohammad Zamani, Dany Saturno, Edward V Loftus Jr, Matthew A Ciorba, Andres Yarur, Siddharth Singh, Parakkal Deepak> ;Clinical Gastroenterology and Hepatology. 2023 Oct 10
• 3 citations
  Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases In...
  Andres J Yarur, Alexandra Bruss, Andrea Moosreiner, Poonam Beniwal-Patel, Lizbeth Nunez, Brandon Berens, Jean F Colombel, Stephan R Targan, Caroline Fox, Gil Y Melmed,...> ;Gastroenterology. 2023 Oct 1
• 4 citations
  Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
  Andres J Yarur, Maria T Abreu, Parakkal Deepak, Poonam Beniwal-Patel, Konstantinos Papamichael, Byron Vaughn, Alexandra Bruss, Shaina Sekhri, Andrea Moosreiner, Philli...> ;The American Journal of Gastroenterology. 2023 Nov 1
• 30 citations
  Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.
  William J Sandborn, Séverine Vermeire, Laurent Peyrin-Biroulet, Marla C Dubinsky, Julian Panes, Andres Yarur, Timothy Ritter, Filip Baert, Stefan Schreiber, Sheldon Sl...> ;Lancet. 2023 Apr 8
• 5 citations
  Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases.
  Paulina Núñez, Rodrigo Quera, Andres J Yarur> ;Drugs. 2023 Mar 1
• A Rare But Devastating Dermatologic Manifestation of Ulcerative Colitis.
  Gabriela N Kuftinec, Jane E Lim, Andres J Yarur> ;Gastroenterology. 2023 May 1
• 5 citations
  Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab.
  Andres J Yarur, Dermot McGovern, Maria T Abreu, Adam Cheifetz, Konstantinos Papamichail, Parakkal Deepak, Alexandra Bruss, Poonam Beniwal-Patel, Marla Dubinsky, Stepha...> ;Clinical Gastroenterology and Hepatology. 2023 Oct 1
• 1 citations
  Current perspectives on pediatric inflammatory bowel disease focusing on transitional care management. What should we consider?
  Constanza Bay M, Paulina Núñez F, Rodrigo Quera, Andrés J Yarur> ;Gastroenterologia y Hepatologia. 2023 Feb 1
• 11 citations
  Inflammatory Bowel Disease Is Associated With an Increased Risk of Incident Acute Arterial Events: Analysis of the United Kingdom Biobank.
  Quazim A Alayo, Edward V Loftus Jr, Andres Yarur, David Alvarado, Matthew A Ciorba, Lisa de Las Fuentes, Parakkal Deepak> ;Clinical Gastroenterology and Hepatology. 2023 Mar 1
• 1 citations
  Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of...
  Parambir S Dulai, Victoria Rai, Laura E Raffals, Dana Lukin, David Hudesman, Gursimran S Kochhar, Oriana M Damas, Jenny S Sauk, Alexander N Levy, M Anthony Sofia, Anne...> ;The American Journal of Gastroenterology. 2022 Aug 1
• 10 citations
  Real-world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure-response relationship of vedolizumab in inflammatory...
  Niels Vande Casteele, William J Sandborn, Brian G Feagan, Séverine Vermeire, Parambir S Dulai, Andres Yarur, Xavier Roblin, Shomron Ben-Horin, Iris Dotan, Mark T Oster...> ;Alimentary Pharmacology & Therapeutics. 2022 Aug 1
• Intestinal Tissue Levels of Anti-Tumour Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases: Are We Looking in The Right Place at The Right Time?
  Andres J Yarur> ;Journal of Crohn's & Colitis. 2022 Jul 14
• 4 citations
  Integrating new and emerging therapies into inflammatory bowel disease clinical practice.
  Shaina Sekhri, Andres J Yarur> ;Current Opinion in Gastroenterology. 2022 Jul 1
• 5 citations
  Therapeutic Drug Monitoring in Perianal Fistulizing Crohn's Disease.
  Mir Zulqarnain, Parakkal Deepak, Andres J Yarur> ;Journal of Clinical Medicine. 2022 Mar 25
• Join now to see all

Journal Articles

• Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases  
  Ryan Ungaro, Daniel J Stein, Andres J Yarur, Amir Patel, Marla Dubinsky, Digestive Diseases and Sciences